Healthcare Facilities & Services

Page 1

Town Health International Medical Group Ltd proposes to issue of new shares

5:18am EDT

Town Health International Medical Group Ltd:Has entered into share subscription agreement with Fubon Life, Fubon Insurance and major shareholder.Pursuant to which Fubon Life has conditionally agreed to subscribe for, and company has conditionally agreed to allot and issue, 259,740,260 subscription shares for HK$254,545,455 in cash.Fubon Insurance has conditionally agreed to subscribe for, and company has conditionally agreed to allot and issue, 97,402,597 subscription shares for HK$95,454,545 in cash.Says major shareholder has conditionally agreed to subscribe for, and company has conditionally agreed to allot and issue, 102,040,816 subscription shares for HK$100,000,000 in cash, each at share subscription price of HK$0.98 per subscription share.Net proceeds from the Share Subscription will be about HK$440 mln.

Vision Eye Institute Limited issues fully paid ordinary shares

Thursday, 23 Oct 2014 05:37pm EDT

Vision Eye Institute Limited:Issues 16,750,000 fully paid ordinary shares issued at $0.60 per share.Says it will be used to fund appropriate acquisition opportunities identified by the VEI Board.

Premier Diagnostic Health Services Inc announces exercise of share purchase warrants

Thursday, 23 Oct 2014 02:17pm EDT

Premier Diagnostic Health Services Inc:Receives notices of warrant exercise from certain warrantholders that they wish to exercise their share purchase warrants into Common shares of the company.Says total proceeds of the warrant exercise are $459,844.25.Says a total of 9,196,885 Common shares are issuable upon the exercise.

Premier Diagnostic Health Services Inc closes second tranche of private placement

Friday, 17 Oct 2014 01:24pm EDT

Premier Diagnostic Health Services Inc:Closes the second tranche of its non-brokered private placement offering of common shares of the company of up to 40,000,000 Shares at $0.18 per Share for aggregate gross proceeds of up to $7,200,000.Company also closed its over allotment option of 4,588,558 shares for gross proceeds of $825,900.45.Total proceeds of the offering and over allotment option were $8,025,900.40.Net proceeds of the Offering will be used to fund expansion of the Company's premier diagnostic medical clinics in China and Canada, as well as for general working capital and investment purposes.Company anticipates that the resulting capitalization combined with new strategies to deliver earnings will be adequate to support growth.

Premier Diagnostic Health Services Inc closes $6 million first tranche of private placement

Thursday, 2 Oct 2014 06:40pm EDT

Premier Diagnostic Health Services Inc:Announces that it has closed first tranche of its non-brokered private placement offering of common shares of the company of up to 40,000,000 Shares at $0.18 per share for aggregate gross proceeds of up to $7,200,000.First tranche consisted of 34,108,028 shares for aggregate gross proceeds of $6,139,445.04, including 415,000 shares issued in settlement of debt.Shares will be subject to a hold period expiring on Feb. 3, 2015.Net proceeds of the offering will be used to fund expansion of the company's diagnostic medical clinics in China and Canada, as well as for general working capital and investment purposes.Anticipates second tranche of offering will close on or about Oct. 15.

Alexandria Medical Services Co SAE gets approval on capital increase through rights issue

Tuesday, 30 Sep 2014 08:00pm EDT

Alexandria Medical Services Co SAE:Announces that the Listing Committee has approved to list the company's capital increase to 48.4 million Egyptian pounds from 24.2 million Egyptian pounds.Says the 24.2 million Egyptian pounds capital increase through rights issue to the existing shareholders are distributed over 2.42 million shares at a par value of 10 Egyptian pounds.

Orpea SA announces increase of number of outstanding ordinary shares

Monday, 29 Sep 2014 08:00pm EDT

Orpea SA:Announces that 37,420 new ordinary shares issued by the company, immediately assimilated with the existing ordinary shares, will be listed on the market Euronext Paris as of Oct. 2.Says the old number of outstanding shares is 55,478,474.Says the number of shares to be listed is 37,420.Says the ne w number of outstanding shares is 55,515,894.

Greencross Limited issues shares

Sunday, 28 Sep 2014 10:35pm EDT

Greencross Limited:167,083 shares at A$9.76 and 626,030 shares at A$9.76.

Envision Healthcare Holdings Inc announces sale of 17,500,000 shares of common stock by selling stockholders

Tuesday, 23 Sep 2014 04:28pm EDT

Envision Healthcare Holdings Inc:Says sale of an aggregate of 17,500,000 shares of company's common stock by investment funds associated with Clayton, Dubilier & Rice, LLC, and certain executive officers and directors of company to Citigroup, as sole underwriter in registered public offering of those shares.Says Selling Stockholders will receive all of net proceeds from this offering.No shares are being sold by company.

Premier Diagnostic Health Services Inc announces $7.2 mln private placement

Wednesday, 10 Sep 2014 04:22pm EDT

Premier Diagnostic Health Services Inc:Says non-brokered private placement offering of common shares of the Company of up to 40,000,000 Shares at $0.18 per Share for aggregate gross proceeds of up to $7,200,000.Management of company reserves right, in its sole discretion and subject to CSE approval, to increase the Offering by 25 pct to up to 50,000,000 Shares for aggregate gross proceeds of up to $9,000,000.There is no minimum Offering amount required to close, and Offering may be closed in tranches.The first closing is expected to occur on or about Sept. 30.The Shares will be issued in reliance on exemptions from prospectus and registration requirements contained in the securities legislation in the Province of British Columbia and in the jurisdiction of residency of each investor.The Shares will be subject to a hold period.The net proceeds of the Offering will be used to fund expansion of company's premier diagnostic medical clinics in China and Canada, as well as for general working capital and investment purposes.Company anticipates that resulting capitalization combined with new strategies to deliver earnings will be adequate to support growth.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Market Edge
$10.00
Provider: Market Edge
$10.00
Provider: Auerbach Grayson & Co., Inc.
$25.00
Provider: Auerbach Grayson & Co., Inc.
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.